46 reports

  • Musculoskeletal Drugs was the largest segment in the region market at 15.5% of the market worth about $6.4 billion.

Drugs For Respiratory Diseases P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A

  • Dermatological Treatment
  • Hepatitis Treatment
  • Managed Care
  • Respiratory Monitoring
  • Market Size

Particularly PDE-## and PDL-## inhibitors, the market is huge.

  • Dermatological Treatment
  • Managed Care
  • World
  • Forecast
  • Galderma S.A.
  • ORPHAN AND RARE DERMATOLOGY DRUGS MARKET, GLOBAL, APPROVED ORPHAN AND
  • 3.3 Highly Genericized Drugs

Stomach tests involve endoscopies (a popular technique to visualize internal body cavities) and gastrointestinal biopsies (taking a sample from inside the patient' s gastrointestinal tract for analysis).

  • Dermatological Treatment
  • World
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation

Scope of Business: ##.

  • Dermatological Treatment
  • Hepatitis Treatment
  • Managed Care
  • China
  • Xian-Janssen Pharmaceutical Ltd.
  • ATRIPLA SWOT ANALYSIS, 2016

BIOSCIENCE TRENDS; ##(##): ##-##.

  • Hepatitis Treatment
  • Managed Care
  • East Asia
  • Gilead Sciences, Inc.
  • ViiV Healthcare Ltd.

We are one of the nation' s Top ## health systems.

  • Managed Care
  • United States
  • Company
  • Supply
  • GlobalData's company

Genotype ## is the most common HCV.

  • Dermatological Treatment
  • Hepatitis Treatment
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson

Scope of Business: ##.

  • Dermatological Treatment
  • Hepatitis Treatment
  • China
  • Novartis AG
  • Xian-Janssen Pharmaceutical Ltd.

Systemic tetracycline may cause gastrointestinal upset, nausea, diarrhea, and vaginal yeast infection.

  • Dermatological Treatment
  • Hepatitis Treatment
  • Managed Care
  • Allergan plc
  • Galderma S.A.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation

Elvitegravir inhibits HIV-## integrase.

  • Dermatological Treatment
  • Hepatitis Treatment
  • United States
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences, Inc.
  • Clinical Trial profile. 187 Trial Title
  • Clinical Trial profile. 341 Trial Title

The prominent features of this report are - ##.

  • Dermatological Treatment
  • Hepatitis Treatment
  • Managed Care
  • Pharmaceutical
  • World

B-## Table of Contents iv U. S.

  • Dermatological Treatment
  • Managed Care
  • United States
  • Covidien plc
  • Smith & Nephew Plc
  • PIPELINE BY EA PHARMA CO LTD, H2 2018
  • INTRODUCTION

The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are ##, ##, ##, ## and ## respectively.

  • Dermatological Treatment
  • Pharmaceutical
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • Dr Reddy's Labs Enters into Licensing Agreement with Hetero Drugs for Sofosbuvir

The drug candidate acts by inhibiting Gag protein (HIV-## Maturation Inhibitor).

  • Dermatological Treatment
  • Hepatitis Treatment
  • Pharmaceutical
  • India
  • Hetero Drugs Limited

This agreement enables Beactica to advance one of their prioritized discovery programmes and enables Medivir to search for hits active against one of its early discovery targets.

  • Healthcare
  • Hepatitis Treatment
  • Pharmaceutical
  • Sweden
  • Medivir UK Ltd.
  • FRESENIUS MEDICAL CARE AG & CO KGAA, DEALS BY THERAPY AREA, 2012 TO YTD 2018

DIALYSIS TREATMENTS INCREASED BY ##%.

  • Hepatitis Treatment
  • Managed Care
  • Australia
  • Company Financials
  • Fresenius Group
  • Mayo Foundation for Medical Education and Research, Deals By Therapy Area, 2011 to YTD 2017

Deal Rationale Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products.

  • Clinic
  • Dermatological Treatment
  • Hepatitis Treatment
  • Managed Care
  • GlobalData's company

One unit is one oximeter sensor.

  • Hepatitis Treatment
  • Managed Care
  • Respiratory Monitoring
  • Sensor
  • GlobalData's company

The company' s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream.

  • Dermatological Treatment
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States

The company' s major products include analgesics, gastrointestinal, personal care and derma therapeutics, colobetasol spray, clindamycin foam, mupirocin ointment, halobetasol ointment and cream and permethrin cream.

  • Dermatological Treatment
  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States

One unit refers to one test kit.

  • Hepatitis
  • Hepatitis Treatment
  • Managed Care
  • RNA
  • Abbott

Deal Rationale Synergy Pharmaceuticals Inc (Synergy Pharma) is a biopharmaceutical company that develops and commercializes new treatments for gastrointestinal (GI) diseases.

  • Hepatitis
  • Hepatitis Treatment
  • Pharmaceutical
  • United States
  • ContraVir Pharmaceuticals, Inc.

GlobalData Prasco LLC, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Dermatological Treatment
  • Healthcare
  • Pharmaceutical
  • United States
  • Prasco, LLC
  • Respiratory Measurement Devices Companies and Product Overview

One unit is one Capnograph.

  • Clinical Trial
  • Hepatitis Treatment
  • Hospital
  • Managed Care
  • Respiratory Monitoring

Major gastrointestinal diseases include irritable bowel syndrome, Crohn' s disease, cirrhosis, liver diseases and hepatitis C infection (HCV), among others.

  • Health Services
  • Hospital
  • Managed Care
  • United States
  • Company

Growth in molecular biology lines was driven by the ongoing fast-paced development of FilmArray®, and in particular the Gastrointestinal and Meningitis/ Encephalitis panels.

  • Heart Failure
  • In Vitro Diagnostic Reagent
  • Managed Care
  • United States
  • bioMerieux S.A.
  • Pipeline by EA Pharma Co Ltd, H1 2018
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

Results from the Phase I study were presented at the 2017 Gastrointestinal Cancers Symposium.

  • Dermatological Treatment
  • Hospital
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • GLOBAL MARKETS DIRECT REPORT COVERAGE

The molecules developed by companies in Phase I, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Dermatological Treatment
  • Hospital
  • Therapy
  • World
  • Product Initiative

The molecules developed by Companies in Phase I, Preclinical and Discovery stages are ##, ## and ## respectively.

  • Dermatological Treatment
  • Therapy
  • World
  • Product Initiative
  • Pfizer Inc.